82 FR 44191 - Notice of Single-Award Deviation From Competition Requirements for the Severe Combined Immunodeficiency (SCID) Newborn Screening Program at the Jeffrey Modell Foundation

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration

Federal Register Volume 82, Issue 182 (September 21, 2017)

Page Range		44191-44191
FR Document		2017-20116

HRSA announces the award of an extension in the amount of $2,000,000 for the Severe Combined Immunodeficiency (SCID) Newborn Screening program at the Jeffrey Modell Foundation (JMF). The extension will allow JMF, the cooperative agreement recipient, during the budget period of May 1, 2017 to April 30, 2018, to provide technical assistance and support to states for the implementation of population based newborn screening for SCID.

Federal Register, Volume 82 Issue 182 (Thursday, September 21, 2017)

[Federal Register Volume 82, Number 182 (Thursday, September 21, 2017)]
[Notices]
[Page 44191]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-20116]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Notice of Single-Award Deviation From Competition Requirements 
for the Severe Combined Immunodeficiency (SCID) Newborn Screening 
Program at the Jeffrey Modell Foundation

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services.

ACTION: Notice of award.

-----------------------------------------------------------------------

SUMMARY: HRSA announces the award of an extension in the amount of 
$2,000,000 for the Severe Combined Immunodeficiency (SCID) Newborn 
Screening program at the Jeffrey Modell Foundation (JMF). The extension 
will allow JMF, the cooperative agreement recipient, during the budget 
period of May 1, 2017 to April 30, 2018, to provide technical 
assistance and support to states for the implementation of population 
based newborn screening for SCID.

FOR FURTHER INFORMATION CONTACT: Jill F. Shuger, ScM, Division of 
Services for Children with Special Health Needs, MCHB, HRSA, 5600 
Fishers Lane, Rockville, Maryland 20857, Phone: (301) 443-3247, Email: 
[email protected].

SUPPLEMENTARY INFORMATION: 
    Intended Recipient of the Award: Jeffrey Modell Foundation.
    Amount of Non-Competitive Awards: $2,000,000.
    Budget Period of Supplemental Funding: May 1, 2017 to April 30, 
2018.
    CFDA Number: 93.110.
    Authority: Public Health Service Act, Sec.  1109, as amended by the 
Newborn Screening Saves Lives Reauthorization Act of 2014 (Public Law 
110-204) (42 U.S.C. 300b-8).
    Justification: The Maternal and Child Health Bureau (MCHB) is 
proposing that JMF continue activities under the current cooperative 
agreement to ensure the implementation of newborn screening for SCID in 
all 50 states, particularly in the states that have yet to implement 
SCID screening (i.e., Alabama, Arizona, Indiana, Kansas, Louisiana, 
Nevada and North Carolina). Using its resources and centers, JMF will 
provide technical assistance in areas of funding, state government 
education, and linkage to expert care and patient access to a national 
network of specialized treatment centers. Further, JMF will continue to 
support states with implementation of SCID screening and follow up as 
well as the immediate treatment of infants identified with SCID. JMF 
will use the data collected from the states to educate clinical 
immunologists, neonatologists and other providers on effective 
screening for SCID. Additionally, JMF will continue to support 
education and awareness of newborn screening for SCID to families and 
health care providers and provide education to primary care providers 
and medically underserved populations.

----------------------------------------------------------------------------------------------------------------
                                                                                  Fiscal year      Fiscal year
                                                                                      2017       2017  estimated
          Grantee/organization name              Grant No.          State          authorized      supplemental
                                                                                 funding level       funding
----------------------------------------------------------------------------------------------------------------
Jeffrey Modell Foundation...................            UG5MC28325         UT       $2,000,000       $2,000,000
----------------------------------------------------------------------------------------------------------------


    Dated: September 7, 2017.
George Sigounas,
Administrator.
[FR Doc. 2017-20116 Filed 9-20-17; 8:45 am]
 BILLING CODE 4165-15-P

Federal Register / Vol. 82, No. 182 / Thursday, September 21, 2017 / Notices 44191

Staff (see ADDRESSES). A link to the SUMMARY: HRSA announces the award Justification: The Maternal and Child
transcript will also be available on the of an extension in the amount of Health Bureau (MCHB) is proposing that
internet at https://www.fda.gov/ $2,000,000 for the Severe Combined JMF continue activities under the
AnimalVeterinary/SafetyHealth/ Immunodeficiency (SCID) Newborn current cooperative agreement to ensure
AntimicrobialResistance/ Screening program at the Jeffrey Modell the implementation of newborn
NationalAntimicrobial Foundation (JMF). The extension will screening for SCID in all 50 states,
ResistanceMonitoringSystem/ allow JMF, the cooperative agreement particularly in the states that have yet to
ucm059172.htm. recipient, during the budget period of implement SCID screening (i.e.,
Dated: September 15, 2017. May 1, 2017 to April 30, 2018, to Alabama, Arizona, Indiana, Kansas,
provide technical assistance and
Anna K. Abram, Louisiana, Nevada and North Carolina).
support to states for the implementation
Deputy Commissioner for Policy, Planning, Using its resources and centers, JMF
of population based newborn screening
Legislation, and Analysis.
for SCID. will provide technical assistance in
[FR Doc. 2017–20108 Filed 9–20–17; 8:45 am] areas of funding, state government
FOR FURTHER INFORMATION CONTACT: Jill
BILLING CODE 4164–01–P education, and linkage to expert care
F. Shuger, ScM, Division of Services for
Children with Special Health Needs, and patient access to a national network
MCHB, HRSA, 5600 Fishers Lane, of specialized treatment centers.
DEPARTMENT OF HEALTH AND Further, JMF will continue to support
Rockville, Maryland 20857, Phone:
HUMAN SERVICES states with implementation of SCID
(301) 443–3247, Email: JShuger@
hrsa.gov. screening and follow up as well as the
Health Resources and Services
immediate treatment of infants
Administration SUPPLEMENTARY INFORMATION:
Intended Recipient of the Award: identified with SCID. JMF will use the
Notice of Single-Award Deviation From Jeffrey Modell Foundation. data collected from the states to educate
Competition Requirements for the Amount of Non-Competitive Awards: clinical immunologists, neonatologists
Severe Combined Immunodeficiency $2,000,000. and other providers on effective
(SCID) Newborn Screening Program at Budget Period of Supplemental screening for SCID. Additionally, JMF
the Jeffrey Modell Foundation Funding: May 1, 2017 to April 30, 2018. will continue to support education and
CFDA Number: 93.110. awareness of newborn screening for
AGENCY: Health Resources and Services Authority: Public Health Service Act, SCID to families and health care
Administration (HRSA), Department of § 1109, as amended by the Newborn providers and provide education to
Health and Human Services. Screening Saves Lives Reauthorization primary care providers and medically
Act of 2014 (Public Law 110–204) (42 underserved populations.
ACTION: Notice of award.
U.S.C. 300b–8).

Fiscal year
Fiscal year 2017
2017
Grantee/organization name Grant No. State estimated
authorized supplemental
funding level funding

Jeffrey Modell Foundation ............................................................................... UG5MC28325 UT $2,000,000 $2,000,000

Dated: September 7, 2017. property such as patentable material, Musculoskeletal Diseases RISK R61/R33 Peer
George Sigounas, and personal information concerning Review.
Administrator. individuals associated with the grant Date: October 11, 2017.
[FR Doc. 2017–20116 Filed 9–20–17; 8:45 am] applications, the disclosure of which Time: 8:00 a.m. to 5:00 p.m.
would constitute a clearly unwarranted Agenda: To review and evaluate grant
BILLING CODE 4165–15–P
invasion of personal privacy. applications.
Place: Bethesda North Marriott Hotel &
Name of Committee: National Institute of Conference Center, 5701 Marinelli Rd,
DEPARTMENT OF HEALTH AND Arthritis and Musculoskeletal and Skin
Bethesda, MD 20852.
HUMAN SERVICES Diseases Special Emphasis Panel; T32
Institutional Training Grant Review. Contact Person: Xincheng Zheng, MD,
National Institutes of Health Date: October 6, 2017. Ph.D., Scientific Review Officer, Scientific
Time: 8:00 a.m. to 5:00 p.m. Review Branch, National Institute of
National Institute of Arthritis and Agenda: To review and evaluate grant Arthritis, Musculoskeletal and Skin Diseases,
Musculoskeletal and Skin Diseases; applications. NIH, 6701 Democracy Boulevard, Suite 820,
Notice of Closed Meetings Place: National Institute of Dental and Bethesda, MD 20892, 301–451–4838,
Craniofacial Research, Democracy One, 6701 xincheng.zheng@nih.gov.
Pursuant to section 10(d) of the Democracy Blvd., Suite 602, Bethesda, MD (Catalogue of Federal Domestic Assistance
Federal Advisory Committee Act, as 20892.
Program Nos. 93.846, Arthritis,
Contact Person: Kan Ma, Ph.D., Scientific
asabaliauskas on DSKBBXCHB2PROD with NOTICES

amended, notice is hereby given of the Musculoskeletal and Skin Diseases Research,
Review Officer, Scientific Review Branch,
following meetings. National Institutes of Health, HHS)
National Institute of Arthritis,
The meetings will be closed to the Musculoskeletal and Skin Diseases, NIH, Dated: September 15, 2017.
public in accordance with the 6701 Democracy Boulevard, Suite 814,
provisions set forth in sections Sylvia L. Neal,
Bethesda, MD 20892, 301–451–4838, mak2@
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., mail.nih.gov. Program Analyst, Office of Federal Advisory
as amended. The grant applications and Committee Policy.
Name of Committee: National Institute of
the discussions could disclose Arthritis and Musculoskeletal and Skin [FR Doc. 2017–20095 Filed 9–20–17; 8:45 am]
confidential trade secrets or commercial Diseases Special Emphasis Panel; Division of BILLING CODE 4140–01–P

VerDate Sep<11>2014 19:03 Sep 20, 2017 Jkt 241001 PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 E:\FR\FM\21SEN1.SGM 21SEN1

Document Created: 2018-10-24 14:35:14
Document Modified: 2018-10-24 14:35:14

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice of award.
Contact		Jill F. Shuger, ScM, Division of Services for Children with Special Health Needs, MCHB, HRSA, 5600 Fishers Lane, Rockville, Maryland 20857, Phone: (301) 443-3247, Email: [email protected]
FR Citation		82 FR 44191

82 FR 44191 - Notice of Single-Award Deviation From Competition Requirements for the Severe Combined Immunodeficiency (SCID) Newborn Screening Program at the Jeffrey Modell Foundation

DEPARTMENT OF HEALTH AND HUMAN SERVICESHealth Resources and Services Administration

Federal Register Volume 82, Issue 182 (September 21, 2017)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration